Qiagen

Yahoo Finance • 2 days ago

Oracle Names Stephen Rusckowski to the Board of Directors

AUSTIN, Texas, Nov. 20, 2025 /PRNewswire/ -- Oracle Corporation (NYSE: ORCL) today announced that it unanimously elected Stephen Rusckowski to Oracle's Board of Directors and increased the size of the Board to 14. The election is effective... Full story

Yahoo Finance • 18 days ago

Qiagen NV Q3 25 Earnings Conference Call At 9:30 AM ET

(RTTNews) - Qiagen NV (QGENF) will host a conference call at 9:30 AM ET on November 5, 2025, to discuss Q3 25 earnings results. To access the live webcast, log on to https://event.webcasts.com/starthere.jsp?ei=1709559&tp_key=263df2a108 T... Full story

Yahoo Finance • 18 days ago

QGEN Crosses Below Key Moving Average Level

In trading on Tuesday, shares of Qiagen NV (Symbol: QGEN) crossed below their 200 day moving average of $44.79, changing hands as low as $43.26 per share. Qiagen NV shares are currently trading off about 3% on the day. The chart below sh... Full story

Yahoo Finance • 18 days ago

Qiagen Non-GAAP EPS of $0.61 beats by $0.02, revenue of $533M beats by $7.09M

* Qiagen press release [https://seekingalpha.com/pr/20292837-qiagen-exceeds-q3-2025-outlook-raises-fy-2025-adj-eps-target-announces-parse-acquisition-and] (QGEN [https://seekingalpha.com/symbol/QGEN]): Q3 Non-GAAP EPS of $0.61 beats by $... Full story

Yahoo Finance • 23 days ago

IWB's Underlying Holdings Could Mean 11% Gain Potential

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied... Full story

Yahoo Finance • last month

Sizing Up Qiagen Shares in 2025 After Recent Earnings Momentum

If you are weighing whether to hold, buy, or avoid Qiagen stock right now, you are not alone. It is one of those companies that keeps popping up on value investors' screens, and for good reason. The last twelve months have brought about a... Full story

Yahoo Finance • 2 months ago

WisdomTree Emerging Markets ex-State-Owned Enterprises Fund declares quarterly distribution of $0.1950

* WisdomTree Emerging Markets ex-State-Owned Enterprises Fund (XSOE [https://seekingalpha.com/symbol/XSOE]) - $0.1950 [https://www.wisdomtree.com/etfs/equity/xsoe]. * 30-Day SEC Yield of 1.37% as of Sept. 24. * Payable Sep 29; for sh... Full story

Yahoo Finance • 2 months ago

Biobanking Market Analysis and Forecast Report 2025-2035: Ethical and Legal Challenges in Biobanking - Navigating Consent and Privacy

Company Logo Driven by demand for personalized medicine and rising chronic diseases, the biobanking market faces ethical and regulatory challenges. Major players include Becton, Dickinson and Company, QIAGEN N.V., and Merck KGaA. Trends l... Full story

Yahoo Finance • 2 months ago

Qiagen N.V. (QGEN) Launches QIAseq xHYB Panels for Long-Read Sequencing

In this article, we will be taking a look at the 7 Hot Healthcare Stocks to Buy Right Now. Qiagen N.V. is placed seventh among them. Qiagen N.V. (NYSE:QGEN), a global leader in molecular diagnostics and sample preparation technologies, co... Full story

Yahoo Finance • 2 months ago

Asia-Pacific Non-Invasive Prenatal Testing Market Growth and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen

Dublin, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Non-Invasive Prenatal Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering. The... Full story

Yahoo Finance • 3 months ago

QIAGEN N.V. Announces Successful Placement of New Net Share Settled Convertible Bonds

VENLO, Netherlands, August 28, 2025--(BUSINESS WIRE)--NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION O... Full story

Yahoo Finance • 3 months ago

Qiagen to raise $750M via non-U.S. offering of convertible bonds

* Qiagen (NYSE:QGEN [https://seekingalpha.com/symbol/QGEN]) board resolved the issue of senior, unsecured net share settled convertible bonds, which may be converted in part into ordinary shares. * The company intends to issue [https:/... Full story

Yahoo Finance • 4 months ago

Non-Invasive Prenatal Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen

Dublin, July 28, 2025 (GLOBE NEWSWIRE) -- The "Non-Invasive Prenatal Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering. Non-Invasive Prena... Full story

Yahoo Finance • 4 months ago

U.S. Minimal Residual Disease Testing Market Trends Analysis Report 2025-2033 | Integration with Personalized Medicines, & Rising Incidence and Prevalence of Hematological Malignancies Fueling Growth

Dublin, July 25, 2025 (GLOBE NEWSWIRE) -- The "U.S. Minimal Residual Disease Testing Market Size, Share & Trends Analysis Report By Technology (Flow Cytometry, PCR, NGS), By Cancer Type (Hematological Malignancy, Solid Tumors), By End Us... Full story

Yahoo Finance • 5 months ago

Qiagen Teams With Gencurix to Expand Digital PCR Cancer Assays

Qiagen N.V. (NYSE:QGEN) ranks among the best CRISPR stocks to buy. Qiagen N.V. (NYSE:QGEN) and Gencurix announced a collaboration on June 18 to provide oncology assays for Qiagen’s QIAcuityDx digital PCR platform.Qiagen Teams With Gencurix... Full story

Yahoo Finance • 5 months ago

Qiagen and Gencurix partner on oncology diagnostic assays

VENLO, Netherlands - QIAGEN (NYSE: QGEN), a $10 billion molecular diagnostics company with excellent financial health according to InvestingPro analysis, and GENCURIX (KOSDAQ: 229000) announced a partnership to develop oncology assays for... Full story

Yahoo Finance • 6 months ago

Qiagen and ID Solutions Partner to Enhance Digital PCR Assays for Oncology Research

On Friday, Qiagen (NYSE:QGEN) announced a new commercial collaboration and joint marketing agreement with French company ID Solutions to expand the availability of digital polymerase chain reaction (dPCR) assays for oncology research appli... Full story

Yahoo Finance • 8 months ago

QIAGEN Announces Form 20-F Annual Report Filing for 2024 Results

VENLO, Netherlands, March 31, 2025--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the... Full story

Yahoo Finance • 9 months ago

QIAGEN Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific Region

New facility reflects QIAGEN’s commitment to enhancing its bioinformatics data center infrastructure in the Australia, New Zealand, New Guinea and surrounding islands region New data center in Melbourne meets Australian regulations to ens... Full story

Yahoo Finance • 10 months ago

Qiagen: Q4 Earnings Snapshot

PL VENLO, Netherlands (AP) — PL VENLO, Netherlands (AP) — Qiagen NV (QGEN) on Wednesday reported fourth-quarter net income of $88.3 million. On a per-share basis, the Pl Venlo, Netherlands-based company said it had profit of 39 cents. Ear... Full story